| Net Cash Provided by (Used in) Operating Activities |
$2,484,000 |
USD |
-144% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$9,359,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$30,000 |
USD |
-233% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$6,845,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$6,403,000 |
USD |
1342% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$9,307,000 |
USD |
19% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$9,431,000 |
USD |
19% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$30,000 |
USD |
233% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$6,769,000 |
USD |
16% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
5,185 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
150,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$232,000 |
USD |
21% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$54,275,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
5,185 |
shares |
|
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$15,000 |
USD |
-21% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |